A Clinical Scenario Knowledge Check - that is a single question from a web based quiz created by Millennium Laboratories Inc. in 2012. The question asks "Sue's PGT results show that he is a CYPD2D6 ultra-rapid metabolizer which is consistent with her UDT results that were negative for tramadol. Given that she is reporting increased adverse effects despite a dose reduction what changes to Sue's treatment plan may her clinician consider to improve her outcomes?" The possible multiple choice answers are: "Switch opioid medication to non-CYPD6" "Treat her adverse effects" "Avoid potential medication interactions" "Augment with another medication" or "Increase the dose".
At the bottom right corner of the image there is a button that says "Submit".
Description
Type
Category
-
Date
2012
Collection
We encourage you to view the image in the context of its source document(s) and cite the source(s) when using these images. However, to cite just this image alone, click the “Cite This Image” button and then paste the copied text.
![A screenshot of a Formulary update page on the Xartemis™ XR (oxycodone HCI and acetaminophen Extended-Release Tablets (CII)) website. It explains that "Xartemis™ Xu is available unrestricted on Tier 3 for State of Connecticut EMP (CT) Commercial Patients. No PA/step therapy requirement. Patients will have an average co-pay of [placeholder]." The page has a white green and grey background with purple menu bar at the bottom.](https://oida-resources-images.azureedge.net/public/full/2d0e21be-f2dc-4e52-a1df-81df18c3880c.jpeg)
